Fundraising Fox
FluidForm
Waltham, US · 1 known investors
Find your way into FluidForm
Sign up to see every warm intro you have to FluidForm
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FluidForm team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FluidForm Bio builds living human tissue using its FRESH 3D bioprinting technology, which forms tissue from cells and proteins for use in pharma, medical device, and regenerative medicine applications. The company partners with life science companies and combines 3D printing, computational and synthetic biology, AI, and materials science to develop tissue for treating disease.
Founders & leadership
MG
Mike GraffeoChief Executive Officer & Co-founder
JP
Jonathan ParisGeneral Counsel & Head of Corporate StrategyHe has extensive experience as a legal executive advising public and private companies across life sciences and other industries on matters including business scaling, product development, manufacturing expansion, and international distribution.
EW
Erik WatersChief Financial OfficerChief Financial Officer of FluidForm, a company developing 3D-printed human tissue for pharmaceutical and regenerative medicine applications. Waters has held C-level leadership positions across multiple sectors including business services, technology, education, energy, and healthcare, with experience in both private equity-backed and venture-backed growth companies.
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 round · 2026
▶$1.7MraisedAug 2026 · 20 investors · BiotechnologyRule 506(b)
▶$1.7MraisedAug 2026 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael GraffeoExecutive Officer, Director
- Adam FeinbergExecutive Officer, Director
- Erik WatersExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.7M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does FluidForm do?
- FluidForm Bio builds living human tissue using its FRESH 3D bioprinting technology, which forms tissue from cells and proteins for use in pharma, medical device, and regenerative medicine applications. The company partners with life science companies and combines 3D printing, computational and synthetic biology, AI, and materials science to develop tissue for treating disease.
- Who founded FluidForm?
- FluidForm was founded by Mike Graffeo, Adam Feinberg.
- Who are FluidForm's investors?
- FluidForm's investors include Hackensack Meridian Health Bear's Den.
- How much funding has FluidForm raised?
- FluidForm has disclosed $1.7M raised across 1 round.
- Where is FluidForm headquartered?
- FluidForm is headquartered in Waltham, US.